Racial differences in longitudinal toxicities of anticancer agents in early phase cancer clinical trials

BACKGROUND: Racial differences have been reported in toxicity outcomes for anticancer drug treatments. However, these observations were often from studies with small sample sizes, and many only reported the maximum grade of toxicity and no longitudinal information. This current analysis aims to inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizusawa, Junki, Sato, Hioryuki, Rubinstein, Larry V., Fujiwara, Takeo, Yonemori, Kan, Hirakawa, Akihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10524029/
https://www.ncbi.nlm.nih.gov/pubmed/37519123
http://dx.doi.org/10.1002/cam4.6370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10524029/
https://www.ncbi.nlm.nih.gov/pubmed/37519123
http://dx.doi.org/10.1002/cam4.6370

Ejemplares similares